Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

The Global Medical Aesthetic Devices Market to Surpass USD 25 billion by 2027 | DelveInsight

Published

on

New York, USA, June 07, 2022 (GLOBE NEWSWIRE) — The Global Medical Aesthetic Devices Market to Surpass USD 25 billion by 2027 | DelveInsight

The medical aesthetic devices market is anticipated to expand due to an increase in the global ageing population. Moreover, shifting preferences toward minimally invasive or non-invasive cosmetic procedures could also bolster the demand for newly developed medical aesthetic devices in the upcoming years.

According to the latest report published by DelveInsight, “Medical Aesthetic Devices Market Insight,” the global medical aesthetic devices market is likely to grow significantly due to an increase in various cosmetic procedures, either surgical or nonsurgical, globally. In addition, factors such as an increase in trauma injuries, different types of cancer requiring reconstructive surgeries following the treatment, a rise in obesity among the population, and growing technological advancement in the product arena are expected to add to the market growth. This report will provide an in-depth understanding of the medical aesthetic devices market, further benefiting the competitors or stakeholders operating in the medical aesthetic devices market.

Key Takeaways From the Medical Aesthetic Devices Market

  • DelveInsight expects North America to dominate the global medical aesthetic devices market during the forecast period. 
  • The leading aesthetic medical device companies such as Johnson & Johnson, HansBioMed., AbbVie Inc., Sebbin, Sientra, Inc., POLYTECH Health & Aesthetics GmbH, Suneva Medical, Hanson Medical Inc., SurgiSil, Surgiform Technologies LLC, Alma Lasers, Candela Medical., Lumenis., Cutera., Sciton Inc., Merz Pharma GmbH & Co. KGaA, Bausch Health Companies Inc., Venus Concept., TRIA BEAUTY, Cynosure Inc., and GALDERMA, are currently working in the medical aesthetic devices market.
  • In May 2021, GC Aesthetics, Inc., a privately-held medical technology company providing aesthetic solutions, launched its next generation of breast implants, PERLE™.
  • In February 2021, Galderma received the US Food and Drug Administration (FDA) approval for Restylane® Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21.
  • In November 2020, Lutronic Introduced Intelligent Care in Muscle Stimulation with IntelliSTIM™ – a third-generation body sculpting device.
  • Thus, due to such developments in the market, rapid growth will be observed in the Medical Aesthetic Devices market during the forecast period.

To read more about the latest highlights related to aesthetic medical devices, get a snapshot of the key highlights covered in the Medical Aesthetic Devices Market Report

Medical Aesthetic Devices

According to the US FDA, medical aesthetic devices are used to treat or enhance a person’s appearance. There are various minimally invasive or noninvasive medical aesthetic devices for various treatments, including skin resurfacing, noninvasive lipolysis, skin laxity, excessive fat, cellulite, scars, moles, and others. 

A rise in the number of various cosmetic procedures worldwide because of an increase in the population who are conscious of their appearance is expected to augment the demand for these devices. 

Medical Aesthetic Devices: Market Insights

Geographically, the global medical aesthetic devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. North America currently leads the global medical aesthetic devices market in revenue share and is projected to hold its market position during the study period. North America’s domination stems from various factors, such as the rising burden of breast cancer, trauma injuries, and an increasing prevalence of obesity. 

In addition, the rising aging population in the region who are likely to lose skin laxity, sagging jowls, wrinkles, and others is expected to increase the demand for aesthetic procedures, thereby increasing the need for medical aesthetic devices. Thus, the rising geriatric population in the region coupled with various external factors that hamper a person’s appearance are likely to increase the regional Medical Aesthetic Devices market. 

To know more about why North America is leading the market growth in the Medical Aesthetic Devices market, get a snapshot of the report Medical Aesthetic Devices Market Analysis

Medical Aesthetic Devices Market Dynamics

The medical aesthetic devices market is expected to grow significantly with the rise in the global elderly population. Furthermore, increased efforts by major players to develop and introduce new and innovative products and active manufacture of various aesthetic devices to cater to the target demographic are expected to drive development in the medical aesthetic devices market in the coming years.

However, the high cost of these devices and procedures, clinical risks and consequences associated with medical aesthetic treatments, and a lack of reimbursement regulations in some countries are some of the factors constraining the global medical aesthetic devices market.

Furthermore, the COVID-19 pandemic has slumped the medical aesthetic devices market due to the canceled or denied elective surgeries across the globe to curb the transmission of the infection. However, due to the approval and administration of numerous COVID-19 vaccines worldwide, the medical aesthetic devices market is projected to regain normalcy during the post-pandemic.

Get a sneak peek at the Medical Aesthetic Devices market dynamics @Medical Aesthetic Devices Market Dynamics Analysis 

Scope of the Medical Aesthetic Devices Market Report 

  • Coverage: Global
  • Study period: 2019–2027
  • Market segmentation by product type – Energy-based aesthetic devices (laser-based aesthetic devices, radiofrequency-based aesthetic devices, light-based aesthetic devices, others), non-energy based aesthetic devices (botulinum toxin, dermal fillers, dermabrasion, and microdermabrasion, implants, others)
  • Market segmentation by application – Skin resurfacing and tightening, body contouring and cellulite reduction, hair removal, facial aesthetic procedures, breast augmentation, others
  • Market segmentation by end-user – Hospitals, dermatology clinics, others
  • Market segmentation by geography – North America, Europe, Asia-Pacific, and the Rest of the World
  • Key aesthetic medical device companies – Johnson & Johnson, HansBioMed., AbbVie Inc., Sebbin, Sientra, Inc., POLYTECH Health & Aesthetics GmbH, Suneva Medical, Hanson Medical Inc., SurgiSil, Surgiform Technologies LLC, Alma Lasers, Candela Medical., Lumenis., Cutera., Sciton Inc., Merz Pharma GmbH & Co. KGaA, Bausch Health Companies Inc., Venus Concept., TRIA BEAUTY, Cynosure Inc., GALDERMA, among others
  • Porter’s five forces analysis, product profiles, case studies, KOL’s views, analyst’s view

DelveInsight Analysis: The medical aesthetic devices market size is expected to grow at a CAGR of 11.46% to reach about USD 25.80 billion by 2027.

Which MedTech key players in the Medical Aesthetic Devices market are set to emerge as the trendsetter explore @Top Medical Aesthetic Device Companies

Table of Contents 

1 Report Introduction
2 Executive summary
3 Regulatory and Patent Analysis
4 Key Factors Analysis
5 Porter’s Five Forces Analysis
6 COVID-19 Impact Analysis on Medical Aesthetic Devices Market
7 Medical Aesthetic Devices Market Layout
8 Global Company Share Analysis – Key 3-5 Companies
9 Medical Aesthetic Devices Market Company and Product Profiles
10 Project Approach
11. About DelveInsight

Interested in knowing the medical aesthetic devices market by 2027? Click to get a snapshot of the Aesthetic Medical Devices 

Related Reports

Scars Pipeline

Scars Pipeline Insight, 2022 report provides comprehensive insights into the pipeline landscape, pipeline drug profiles, including clinical and nonclinical stage products, and the key scars companies such as Roche, OliX Pharmaceuticals, Bonti, etc. 

Burns Market
Burns Market Insight, Epidemiology and Market Forecast, 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Burns companies such as MediWound Germany GmbH/Kaken Pharmaceutical Co., Ltd., and KerecisMallinckrodt Pharmaceuticals.

Medical Protective Equipment Market

Medical Protective Equipment Market Insight, Competitive Landscape and Market Forecast, 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Medical Protective Equipment companies such as 3M, ANSELL LTD, DuPont, and Honeywell International Inc.

Medical Tourism Market

Medical Tourism Market Insight, Competitive Landscape and Market Forecast, 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Medical Tourism companies such as Apollo Hospitals Enterprise Ltd., Fortis Healthcare, Samitivej PCL., and KPJ Healthcare Behard.

Medical Device Contract Manufacturing Market

Medical Device Contract Manufacturing Market Insight, Competitive Landscape and Market Forecast, 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Medical Device Contract Manufacturing companies such as Flex, Ltd., Integer Holdings Corporation, Gerresheimer AG, and Sanmina Corporation.

Medical Exoskeletons Market 

Medical Exoskeletons Market Insight, Competitive Landscape and Market Forecast, 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Medical Exoskeletons companies such as ReWalks Robotics Ltd, Wearable Robotics srl, Ekso Bionics, and CYBERDYNE INC.

Other Trending Reports
India Healthcare Outlook | Tumor Ablation Market | Wide-Neck Bifurcation Intracranial Aneurysms Market | Psychosis Market | Respiratory Distress Syndrome Market | Total Knee Arthroplasty Market | Artificial Cornea and Corneal Implant Market | Pneumothorax Treatment Devices Market | Dental Lasers Market | Glomerulonephritis Market | Trastuzumab Market | Morquio Disease Market | Global Kinase Inhibitor in Autoimmune Diseases Market | Opioid-related Disorders Market | Nocturnal Enuresis Market

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  

Contact Us

Shruti Thakur 

[email protected] 

+1(919)321-6187 

https://www.delveinsight.com/medical-devices

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Aetina Accelerates Embedded AI with High-performance, Small Form-factor Aetina IA380E-QUFL Graphics Card

Published

on

aetina-accelerates-embedded-ai-with-high-performance,-small-form-factor-aetina-ia380e-qufl-graphics-card

TAIPEI, April 25, 2024 /PRNewswire/ — Aetina, a leading Edge AI solution provider, announced the launch of the Aetina IA380E-QUFL at Embedded World 2024 in Nuremberg, Germany. This groundbreaking product is a small form factor PCIe graphics card powered by the high-performance Intel Arc A380E GPU. 

Unmatched Power in a Compact Design
The Aetina IA380E-QUFL delivers workstation-level performance packed into a low-profile, single-slot form factor. This innovative solution consumes only 50W, making it ideal for space and power-constrained edge computing environments. Embedded system manufacturers and integrators can leverage the power of 4.096 TFLOPs peak FP32 performance delivered by the Intel Arc A380E GPU[1].
Beyond Small Size: Big Capabilities
Despite its compact size, the IA380E-QUFL offers native support for 4 mini-DisplayPort outputs and 6GB of GDDR6 memory, enabling the connection of multiple high-resolution displays (UHD). This makes the IA380E-QUFL an excellent choice for a wide range of applications, including commercial gaming, video walls, medical imaging, and visual inference for smart cities.
“The demand for slim and energy-efficient AI systems is rapidly escalating,” said Jackal Chen, Senior Product Manager at Aetina. “The Aetina IA380E-QUFL addresses this need head-on, offering a powerful GPU solution in a compact, single-slot form factor with minimal power consumption. This empowers developers to create powerful and efficient edge systems for a wide range of applications.”.
Unparalleled Commitment: 5-Year Product Supply
Acknowledging the critical need for long-term product stability in industrial applications, Aetina ensures a 5-year product supply for the Aetina IA380E-QUFL, which streamlines system roadmaps and reduces the need for costly redesign. Our commitment is aligned with Intel’s announced product plans for the Intel Arc A380E GPU.[1]
[1]https://www.intel.com/content/www/us/en/content-details/820389/intel-arc-gpu-for-the-edge-public-30-3-30.html?wapkw=Intel%20Arc%20GPU%2030-3-30&DocID=820389 Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries.
Photo –  https://mma.prnewswire.com/media/2395995/High_performance_Small_Form_factor_Aetina_IA380E_QUFL_Graphics_Card.jpg

View original content:https://www.prnewswire.co.uk/news-releases/aetina-accelerates-embedded-ai-with-high-performance-small-form-factor-aetina-ia380e-qufl-graphics-card-302125786.html

Continue Reading

Artificial Intelligence

IG Canada Announces Enhanced Trading Platform for Enhanced User Experience

Published

on

ig-canada-announces-enhanced-trading-platform-for-enhanced-user-experience

Meta description : Explore IG Canada’s advanced trading platform, educational resources, and robust security features. Achieve your trading goals with the innovative tools.
NOTTINGHAM, England, April 25, 2024 /PRNewswire/ — IG Canada, a premier online trading platform, is pleased to announce significant enhancements to its trading technology, designed to empower both novice and experienced traders with superior tools and resources. This development is part of IG Canada’s commitment to providing the best trading experience in the Canadian market.

IG Canada has upgraded its platform with advanced features that streamline trading processes and improve the accuracy of trade execution. These enhancements include customizable charts, a wider range of indicators, and improved mobile access, ensuring traders can operate efficiently from anywhere at any time.
Recognizing the importance of education in trading success, IG Canada has expanded its educational resources. The brokerage now offers a comprehensive learning center featuring webinars, tutorials, and articles that cater to various skill levels. These resources are designed to help traders develop robust trading strategies and improve their market knowledge.
Security remains a top priority for IG Canada. The latest updates include enhanced encryption and multi-factor authentication to protect client data and funds. These security measures provide peace of mind for traders, knowing their investments are safeguarded against potential threats.
IG Canada is a leading online brokerage that provides trading services across multiple asset classes, including forex, stocks, commodities, and indices. With a focus on innovation and customer service, IG Canada is committed to helping Canadian traders achieve their investment goals through a transparent and efficient trading environment.
In addition, IG Canada is committed to engaging with the community through upcoming webinars, live events, and partnerships with local financial experts. These initiatives are designed not only to support the growth and education of the clients but also to foster a stronger, more connected trading community in Canada.
Press Contact:Contact Name: Timothy C. SherwinEmail: [email protected] Phone: +447 441425053

View original content:https://www.prnewswire.co.uk/news-releases/ig-canada-announces-enhanced-trading-platform-for-enhanced-user-experience-302127189.html

Continue Reading

Artificial Intelligence

Sentrycs Now Part of the UK National Protective Security Authority Catalog of Security Equipment

Published

on

sentrycs-now-part-of-the-uk-national-protective-security-authority-catalog-of-security-equipment

This inclusion into the NPSA CSE marks a significant milestone in the company’s commitment to enhancing national and international airspace security and to leading the C-UAS market toward multi-layer strategy optimization and excellence.
TEL-AVIV, Israel, April 25, 2024 /PRNewswire/ — Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).
 
Following a rigorous assessment process, Sentrycs’ cutting-edge Counter Unmanned Aerial Systems (C-UAS) solution has met the high standards set by the NPSA for Detection, Tracking, and Identification (DTI). The testing, conducted at the NPSA’s designated testing facilities in August 2023, rigorously evaluated the Sentrycs system against the NPSA’s DTI Testing and Evaluation Standard v3.1.
Sentrycs elected to be assessed under Configuration D as a 3D system with Ground Control Station (GCS) detection capability and platform identification capability, which is the most demanding test scenario with the highest number of scored parameters.
The Sentrycs system demonstrated exceptional capabilities in various security scenarios, showcasing its robustness in detecting and tracking with high accuracy and zero false alarms. The system’s innovative use of cyber techniques to extract data from targets and its streamlined human-machine interface were especially noted for their efficiency and ease of use.
“Our team is proud to have Sentrycs recognized by the UK National Protective Security Authority,” said Yoav Zaltzman, CEO of Sentrycs. “Being listed in the CSE is not just an honor; it’s a testament to our technology’s reliability and effectiveness in contributing to the ever-changing airspace security landscape.”
Sentrycs’ technology is now accessible through the NPSA CSE, providing security practitioners with verified solutions that meet the UK’s rigorous security standards. This inclusion not only underscores Sentrycs’ role in advancing security technology but also enhances its visibility and credibility on a global stage.
For more details on Sentrycs’ solutions and their impact, visit www.sentrycs.com.
For further information regarding the NPSA and the Catalog of Security Equipment, please visit the NPSA’s official website.
About Sentrycs
Sentrycs is a leader in adaptive counter-drone solutions, supported by innovative technology designed to passively identify, mitigate, and where necessary, intercept unauthorized drones custom-built for various environments – including airports, borders, prisons, critical infrastructure, and mass events. Founded in 2017, Sentrycs’ has offices in Israel and the US, serving customers worldwide. By uniting its field-proven technology and expertise in global drone environments, Sentrycs is leading the way towards a safer and more secure drone-driven future. Learn more at www.sentrycs.com
Video – https://www.youtube.com/watch?v=YBuhpTq5QuM

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/sentrycs-now-part-of-the-uk-national-protective-security-authority-catalog-of-security-equipment-302126952.html

Continue Reading

Trending